By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regen BioPharma  

4700 Spring Street
Suite 304
La Mesa  California  91942  U.S.A.
Phone: 619-702-1404 Fax: 619-330-2328


SEARCH JOBS








Company News
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer 9/17/2014 9:43:19 AM
Regen BioPharma Provides Update On HemaXellerate IND Progress After Conference Call With FDA 9/12/2014 11:49:37 AM
Regen BioPharma Provides Update On dCellVax Breast Cancer Immunotherapy 8/5/2014 10:50:45 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Subsidiary Regen BioPharma Collaborates On Research Paper Analyzing The Use Of Gene Silencing In Heart Transplants 6/12/2014 10:17:07 AM
Regen BioPharma , A Majority Owned Subsidiary Of Bio-Management, Provides Update On Hemaxellerate I™ IND For Treatment Of Drug Resistant Aplastic Anemia 5/13/2014 10:05:10 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces Dividend Record Date To Receive Shares In Its Subsidiary Regen BioPharma 3/7/2014 9:42:10 AM
Regen BioPharma Announces HemaXellerate I™ Efficacy Data In Animal Model Of Aplastic Anemia 12/11/2013 10:29:40 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces 20 Million Share Regen BioPharma Dividend to be Paid to Shareholders 10/10/2013 8:47:32 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Subsidiary Regen BioPharma Enters Into Preclinical Trials Agreement for HemaXellerate I Covering Aplastic Anemia 9/26/2013 9:30:20 AM
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product 9/25/2013 9:13:36 AM
12
//-->